A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Angiex, Inc.
Angiex, Inc.
Nanjing Sanhome Pharmaceutical, Co., Ltd.
EtiraRx Australia Pty Ltd
Novita Pharmaceuticals, Inc.
Columbia University
Tvardi Therapeutics, Incorporated
NantBioScience, Inc.
Xencor, Inc.
Pfizer
Second Affiliated Hospital of Guangzhou Medical University
Celldex Therapeutics
Xencor, Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Novartis
Zhujiang Hospital
University of Chicago
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Santa Maria Biotherapeutics
Curis, Inc.
Memorial Sloan Kettering Cancer Center
Duke University
University of Chicago
Duke University
AstraZeneca
Envita Medical Center, Inc.